SOPHiA GENETICS Reports Fourth Quarter and Year End 2022 Financial Results

Mar 7 2023
Fourth Quarter Revenue Growth Accelerates; Operating Losses Notably Moderate BOSTON & LAUSANNE, Switzerland --(BUSINESS WIRE)--Mar. 7, 2023-- SOPHiA GENETICS SA (Nasdaq: SOPH), a cloud-native software company in the healthcare space, today announced financial results for its fourth quarter and full

Read more

Build something bigger than your career

Enjoyed learning about life at SOPHiA from our blogs? Here are a few of our open roles

Title Country Department
Subject Matter Expert - APAC Malaysia. Singapore Clinical Sales
Senior Director, Clinical & BioPharma Operations Switzerland Medical
Sr Manager, Genomic Implementation Solutions United States Clinical Sales
Deal Desk and Commercial Operations Manager Switzerland. United States Clinical Sales
Events and Marketing Communications Manager United States Marketing & Communications